# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
AbbVie petitions the U.S. Supreme Court to protect its corporate records, arguing a lower court ruling threatens attorney-clien...
Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and raises the price target fr...
Baird analyst Eric Coldwell maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $679 to $694.
Rite Aid's restructuring plan, approved by a U.S. bankruptcy judge, reduces $2 billion in debt and shifts control to lender...
B of A Securities analyst Michael Cherny maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $590 to $...
Argus Research analyst David Toung maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $570 to $670.